Synonyms: GSK3772701 | GSK701 | MMV1582367
Compound class:
Synthetic organic
Comment: MMV367 is an antimalarial clinical candidate, selected from a new class of pyrrolidinamide-containing compounds identified from a phenotypic screen. The chemical structure was first disclosed during the 265th National Meeting of the American Chemical Society (Boston, 2018) [4] and is one of the structures claimed in patent WO2019145360A1 [2].
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. |
|
Bioactivity Comments |
MMV367 is reported to target P. falciparum acyl-CoA synthetase (PfACS10; PF3D7_0525100) [1]. However, we have been unable to find publicly available bioactivity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target. |